journal article·2023-07-08Open access

Adipolin, Chemerin, Neprilysin and Metabolic Disorders Associated with Obesity

Marcelina Sperling, Teresa Grzelak, Marta Pelczyńska, Paweł Bogdański, Krystyna Czyżewska, Dorota Formanowicz

Applied Sciences· Volume 13· Issue 14

Abstract

Adipolin, neprilysin, and chemerin have pleiotropic properties; therefore, their concentrations may influence health complications associated with obesity. The study aimed to search the relationship between adipokine levels and anthropometric and metabolic parameters as well as blood pressure values, taking into account the influence of gender and age. The study group consisted of 88 people aged 30–60 years. It was found that chemerin concentration is positively correlated with glycaemia in the 120′ OGTT (rs = 0.412; p = 0.030) in obese women. There was a negative correlation between adipolin and LDL-C serum concentration (rs = −0.414; p = 0.044) in obese individuals with normal glucose tolerance and a positive correlation between chemerin concentration and triglyceridemia (rs = 0.333; p = 0.033) in the men. Moreover, high chemerin levels (above median values) were observed 3.79 times more frequently (OR = 3.79; 95% CI: 1.03–13.91; p = 0.040) in the male population characterized by elevated triglyceride levels (above 1.7 mmol/L). In the logistic regression analyses, we found that the frequency of high plasma adipolin concentrations increases with age (p = 0.005) only in people with a BMI < 30 kg/m2. It was also shown that the concentrations of the studied adipokines are interrelated. Adipolin, neprilysin and chemerin concentrations are associated with selected anthropometric and metabolism exponents.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Adipokines, Inflammation, and Metabolic Diseases · Cardiovascular Disease and Adiposity · Adipose Tissue and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Chemistry and Laboratory Medicine, Poznan University of Medical Sciences, 8 Rokietnicka Street, 61-701 Poznań, Poland

Department of Physiology, Poznan University of Medical Sciences, 6 Święcickiego Street, 60-781 Poznań, Poland

Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, 84 Szamarzewskiego Street, 60-569 Poznań, Poland

Department of Nursing, Stanislaw Staszic State University of Applied Sciences in Pila, 10 Podchorążych Street, 64-920 Piła, Poland

Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants-National Research Institute, Kolejowa 2, 62-064 Plewiska, Poland

References (57)

Show source-provided references
1. World Health Organization (2021). Obesity and Overweight, World Health Organization. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
2. Sick fat: The good and the bad of old and new circulating markers of adipose tissue inflammation10.1007/s40618-019-01052-3 ↗
3. Kojta, I., Chacińska, M., and Błachnio-Zabielska, A. (2020). Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Nutrients, 12.10.3390/nu12051305 ↗
4. Role of type 2 diabetes and hemodialysis in serum adipolin concentrations: A preliminary study10.1111/hdi.12787 ↗
5. Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism10.1074/jbc.M111.277319 ↗
6. CTRP12 ablation differentially affects energy expenditure, body weight, and insulin sensitivity in male and female mice10.1152/ajpendo.00533.2019 ↗
7. CTRP12 inhibits triglyceride synthesis and export in hepatocytes by suppressing HNF-4α and DGAT2 expression10.1002/1873-3468.13895 ↗
8. Chemerin: A multifaceted adipokine involved in metabolic disorders10.1530/JOE-18-0174 ↗
9. Effect of lifestyle modification on serum chemerin concentration band its association with insulin sensitivity in overweight and obese adults with type 2 diabetes10.1111/cen.12249 ↗
10. Chemerin as an early marker of metabolic syndrome10.18544/PEDM-24.01.0102 ↗
11. Neprilysin expression and functions in development, ageing and disease10.1016/j.mad.2020.111363 ↗
12. Neprilysin deficiency protects against fat-induced insulin secretory dysfunction by maintaining calcium influx10.2337/db11-1593 ↗
13. Neprilysin deficiency is associated with expansion of islet β-cell mass in high fat-fed mice10.1369/0022155418765164 ↗
14. Sperling, M., Grzelak, T., Pelczyńska, M., Bogdański, P., Formanowicz, D., and Czyżewska, K. (2023). Association of Serum Omentin-1 Concentration with the Content of Adipose Tissue and Glucose Tolerance in Subjects with Central Obesity. Biomedicines, 11.10.3390/biomedicines11020331 ↗
15. World Health Organization, and International Diabetes Federation (1999). Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications, World Health Organization. Available online: https://apps.who.int/iris/handle/10665/66040.
16. ESC Scientific Document Group, 2018 ESC/ESH Guidelines for the management of arterial hypertension, The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)10.1093/eurheartj/ehy339 ↗
17. An exploratory technique for investigating large quantities of categorical data
18. Hosmer, D.W., Lemeshow, S.A., and Sturdivant, R.X. (2013). Applied Logistic Regression, Wiley. [3rd ed.].10.1002/9781118548387 ↗
19. Bai, B., Ban, B., Liu, Z., Zhang, M.M., Tan, B.K., and Chen, J. (2017). Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in type 2 diabetes mellitus: In vivo regulation by glucose. PLoS ONE, 12.10.1371/journal.pone.0172271 ↗
20. Correlation of serum adipolin with epicardial fat thickness and severity of coronary artery diseases in acute myocardial infarction and stable angina pectoris patients10.1159/000508834 ↗
21. Circulatory changes of the novel adipokine adipolin/CTRP 12 in response to metformin treatment and an oral glucose challenge in humans10.1111/cen.12438 ↗
22. Decreased serum levels of CTRP12/adipolin in patients with coronary artery disease in relation to inflammatory cytokines and insulin resistance10.1016/j.cyto.2018.09.019 ↗
23. Proportional correlates of adipolin and cathepsin S in metabolic syndrome patients with and without prediabetes10.1016/j.dsx.2019.06.010 ↗
24. Neprilysin, obesity and the metabolic syndrome10.1038/ijo.2010.227 ↗
25. Serum neprilysin levels are elevated in preeclampsia10.1016/j.tjog.2021.07.015 ↗
26. Decreases in neprilysin and vasoconstrictors and increases in vasodilators following bariatric surgery10.1111/dom.13320 ↗
27. Low-fat hypocaloric diet reduces neprilysin in overweight and obese human subjects10.1002/ehf2.13220 ↗
28. Fatima, S.S., Bozaoglu, K., Rehman, R., Alam, F., and Memon, A.S. (2013). Elevated chemerin levels in Pakistani men: An interrelation with metabolic syndrome phenotypes. PLoS ONE, 8.10.1371/journal.pone.0057113 ↗
29. Chemerin activation in human obesity10.1002/oby.21534 ↗
30. Circulating chemerin levels, anthropometric indices and metabolic profile in morbid10.37358/RC.18.6.6337 ↗
31. Rowicka, G., Dyląg, H., Chełchowska, M., Weker, H., and Ambroszkiewicz, J. (2020). Serum calprotectin and chemerin concentrations as markers of low-grade inflammation in prepubertal children with obesity. Int. J. Environ. Res. Public Health, 17.10.3390/ijerph17207575 ↗
32. C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes10.1074/jbc.M111.303651 ↗
33. Insulin regulates the novel adipokine adipolin/CTRP12: In vivo and ex vivo effects10.1530/JOE-13-0537 ↗
34. Reduced serum CTRP12 levels in type 2 diabetes are associated with renal dysfunction10.1007/s11255-020-02591-y ↗
35. Neprilysin inhibition: A new therapeutic option for type 2 diabetes?10.1007/s00125-019-4889-y ↗
36. Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity10.1080/14728222.2016.1254198 ↗
37. The changing features of serum adropin, copeptin, neprilysin and chitotriosidase which are associated with vascular endothelial function in type 2 diabetic retinopathy patients10.1016/j.jdiacomp.2020.107686 ↗
38. Association between soluble neprilysin and diabetes: Findings from a prospective longitudinal study10.3389/fendo.2023.1143590 ↗
39. Chemerin: A potential endocrine link between obesity and type 2 diabetes10.1007/s12020-012-9698-8 ↗
40. Role of multifunctional Chemerin in obesity and preclinical diabetes10.1016/j.orcp.2015.01.004 ↗
41. Cătoi, A.F., Pârvu, A.E., and Andreicuț, A.D. (2018). Metabolically healthy versus unhealthy morbidly obese: Chronic inflammation, nitro-oxidative stress, and insulin resistance. Nutrients, 10.10.3390/nu10091199 ↗
42. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome10.1210/jc.2012-3673 ↗
43. Chemerin expression in Chinese pregnant women with and without gestational diabetes mellitus10.1016/j.ando.2014.10.001 ↗
44. Circulating adipokines in healthy versus unhealthy overweight and obese subjects10.1155/2014/170434 ↗
45. Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: Adipose depot specificity and gender dimorphism10.1007/s10059-012-0012-7 ↗
46. Partial deficiency of CTRP12 alters hepatic lipid metabolism10.1152/physiolgenomics.00111.2016 ↗
47. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome10.2169/internalmedicine.50.5025 ↗
48. Circulating chemerin level is independently correlated with arterial stiffness10.5551/jat.9647 ↗
49. Serum and adipose tissue chemerin is differentially related to insulin sensitivity10.1530/EC-20-0084 ↗
50. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery10.1210/jc.2009-2374 ↗
51. Chronic ethanol consumption increases the levels of chemerin in the serum and adipose tissue of humans and rats10.1038/aps.2012.11 ↗
52. Chemerin regulates crosstalk between adipocytes and vascular cells through Nox10.1161/HYPERTENSIONAHA.115.05616 ↗
53. Effects of chemerin/CMKLR1 in obesity-induced hypertension and potential mechanism
54. Chu, S.H., Lee, M.K., and Ahn, K.Y. (2012). Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS ONE, 7.10.1371/journal.pone.0034710 ↗
55. Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension10.2310/JIM.0b013e3181ec5db2 ↗
56. The association of serum chemerin level with risk of coronary artery disease in Chinese adults10.1007/s12020-011-9550-6 ↗
57. Shanaki, M., Moradi, N., Fadaei, R., Zandieh, Z., Shabani, P., and Vatannejad, A. (2018). Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesity. PLoS ONE, 13.10.1371/journal.pone.0208059 ↗